Clinical Trial Update: Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State [Phase 1]

View source ↗

Summary

Phase 1 bioavailability study comparing fixed-dose combination dapagliflozin/metformin XR to the individual components in healthy subjects under fasting conditi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• metformin XR (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 1 | Status: COMPLETED